France will not use AstraZeneca against new strains of COVID-19

“We are continuing to use this vaccine now as it helps us get out of the crisis.

However, in order to respond to the threat of new strains, we need other vaccines that are more effective, ”TASS quoted Macron as saying.

He noted that "this approach is dictated by pragmatism."

Macron thus supported the decision previously announced by the EU representative not to renew the contract for the supply of the AstraZeneca vaccine for the second half of 2021.

Earlier, the EC approved a contract for the supply of up to 1.8 billion doses of BioNTech / Pfizer vaccine.